Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Medicinas Complementárias
Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
2.
J Immunol ; 186(4): 2087-94, 2011 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-21228351

RESUMEN

The hepatitis C virus (HCV) nonstructural 5A, a phosphorylated zinc metalloprotein, is an essential component of the HCV replication complex. An amphipathic α-helical peptide (HCV peptide [C5A]) derived from nonstructural 5A membrane anchor domain possesses potent anti-HCV and anti-HIV activity in vitro. In this study, we aimed to investigate the potential of HCV peptide (C5A) to regulate host immune responses. The capacity of HCV peptide (C5A) in vitro to induce migration and calcium mobilization of human phagocytes and chemoattractant receptor-transfected cells was investigated. The recruitment of phagocytes in vivo induced by HCV peptide (C5A) and its adjuvant activity were examined. The results revealed that HCV peptide (C5A) was a chemoattractant and activator of human phagocytic leukocytes by using a G-protein coupled receptor, namely formyl peptide receptor. In mice, HCV peptide (C5A) induced massive phagocyte infiltration after injection in the air pouch or the s.c. region. HCV peptide (C5A) also acted as an immune adjuvant by enhancing specific T cell responses to Ag challenge in mice. Our results suggest that HCV peptide (C5A) derived from HCV regulates innate and adaptive immunity in the host by activating the formyl peptide receptor.


Asunto(s)
Fragmentos de Péptidos/fisiología , Fagocitos/inmunología , Fagocitos/metabolismo , Receptores de Formil Péptido/metabolismo , Receptores de Lipoxina/metabolismo , Proteínas no Estructurales Virales/fisiología , Inmunidad Adaptativa , Secuencia de Aminoácidos , Animales , Línea Celular Tumoral , Femenino , Células HEK293 , Humanos , Inmunidad Innata , Proteínas de la Membrana/fisiología , Ratones , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Monocitos/inmunología , Monocitos/metabolismo , Monocitos/virología , Fragmentos de Péptidos/química , Fagocitos/virología , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína , Ratas , Receptores de Formil Péptido/fisiología , Receptores de Lipoxina/fisiología , Proteínas no Estructurales Virales/química
3.
Pharm Biol ; 48(8): 883-90, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20673175

RESUMEN

CONTEXT: We recently reported that F2, an oligomer procyanidin fraction isolated from grape seeds, triggered an original form of cell death in U-87 human glioblastoma cells with a phenotype resembling morphological characteristics of paraptosis. However, the specific death mode induced by F2 and the mechanism of its action have not been assessed so far. OBJECTIVE: In the present work, we therefore further investigated the death mode of human glioblastoma cells induced by F2 and gained insight into the nature of the signaling pathways activated by F2 in glioblastoma cells. MATERIALS AND METHODS: Cell viability assay using MTT, (AO/EB) double staining, Western blot analysis, and Ca2+ assay using fura-2. RESULTS: Morphology studies revealed extensive cytoplasmic vacuolization in dying cells and no apoptotic body formation, membrane bleb formation, or nuclear fragmentation, though some was accompanied by MAPK activation and new protein synthesis, and was independent of caspase activation. Moreover, we demonstrated the involvement of calcium mobilization in F2-induced U-87 cell signaling. DISCUSSION AND CONCLUSION: Altogether we showed that F2 induced a kind of cell death resembling paraptosis in U-87 cells. The current report complements previous studies on the characterization of F2-induced U-87 cell death, enhances our understanding of the action mechanism of F2 on glioma, and helps in the development of novel antitumor therapeutics.


Asunto(s)
Apoptosis/efectos de los fármacos , Glioblastoma/patología , Extractos Vegetales/farmacología , Proantocianidinas/farmacología , Semillas , Vitis , Apoptosis/fisiología , Señalización del Calcio/efectos de los fármacos , Señalización del Calcio/fisiología , Muerte Celular/efectos de los fármacos , Muerte Celular/fisiología , Línea Celular Tumoral , Humanos , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Proantocianidinas/química , Proantocianidinas/aislamiento & purificación
4.
Int Immunopharmacol ; 9(9): 1126-30, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19426837

RESUMEN

Although green tea polyphenol catechin is considered as a potential anti-inflammatory agent, its effect on bacterial component-induced inflammation has been poorly investigated. We examined the capacity of epigallocatechin gallate (EGCG) to regulate leukocyte responses to bacterial chemotactic peptide N-formylmethionyl-leucyl-phenylalanine (fMLF), which is recognized by a human G protein-coupled receptor FPR on phagocytic leukocytes. Pretreatment of human monocytic cells or FPR-transfected rat basophilic leukemia cells (ETFR cells) with EGCG significantly inhibited fMLF-induced chemotaxis. Intraperitoneal administration of EGCG in mice suppressed fMLF-induced leukocyte infiltration into the air pouch created in the skin. Mechanistic studies revealed that EGCG dose-dependently suppressed fMLF-induced calcium flux in monocytic cells and ETFR cells. fMLF-induced ETFR cell migration was significantly inhibited by a specific MEK1/2 inhibitor, PD98059, which was associated with reduction in fMLF-induced ERK1/2 phosphorylation. These results suggest that EGCG inhibits FPR-mediated leukocyte activation thus is a promising anti-inflammatory compound.


Asunto(s)
Antioxidantes/farmacología , Catequina/análogos & derivados , Monocitos/metabolismo , N-Formilmetionina Leucil-Fenilalanina/metabolismo , Animales , Proteínas Quinasas Dependientes de Calcio-Calmodulina/antagonistas & inhibidores , Camellia sinensis/inmunología , Catequina/farmacología , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Movimiento Celular/inmunología , Flavonoides/farmacología , Humanos , Inflamación , Inyecciones Intraperitoneales , Leucemia Basofílica Aguda/sangre , Leucemia Basofílica Aguda/tratamiento farmacológico , Leucemia Basofílica Aguda/inmunología , Ratones , Monocitos/efectos de los fármacos , Monocitos/inmunología , N-Formilmetionina Leucil-Fenilalanina/inmunología , Ratas , Receptores de Formil Péptido/genética , Receptores de Formil Péptido/inmunología , Receptores de Formil Péptido/metabolismo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/inmunología , Transfección , Transgenes
5.
Chem Biol Interact ; 179(2-3): 419-29, 2009 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-19167369

RESUMEN

Gliomas are the most common and lethal tumor type in the brain. The present study investigated the effect of oligomer procyanidins (F2) (F2, degree of polymerization 2-15), a natural fraction isolated from grape seeds on the biological behavior of glioblastoma cells. We found that F2 significantly inhibited the glioblastoma growth, with little cytotoxicity on normal cells, induced G2/M arrest and decreased mitochondrial membrane potential in U-87 cells. It also induced a non-apoptotic cell death phenotype resembling paraptosis in U-87 cells. In addition, it was found for the first time that F2 in non-cytotoxic concentrations selectively inhibited U-87 cell chemotaxis mediated by a G-protein coupled receptor formyl peptide receptor FPR, which is implicated in tumor cell invasion and metastasis. Further experiments indicated that F2 inhibited fMLF-induced U-87 cell calcium mobilization and MAP kinases ERK1/2 phosphorylation. Moreover, F2 attenuated the glioblastoma FPR expression, a new molecular target for glioma therapeutics, which has been shown to play important roles in glioma cells chemotaxis, proliferation and angiogenesis in addition to its promotion to tumor progression, but did not affect FPR mRNA expression in U-87 cells. Taken together, our results suggest that F2 may be a promising candidate for the development of novel anti-tumor therapeutics.


Asunto(s)
Glioblastoma/metabolismo , Glioblastoma/patología , Extractos Vegetales/farmacología , Proantocianidinas/farmacología , Receptores de Formil Péptido/antagonistas & inhibidores , Semillas/química , Vitis/química , Ciclo Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Membranas Mitocondriales/efectos de los fármacos , Membranas Mitocondriales/metabolismo , Estructura Molecular , Proantocianidinas/química , Proantocianidinas/aislamiento & purificación , Receptores de Formil Péptido/metabolismo , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA